Moleculin Biotech (MBRX) Operating Leases (2019 - 2026)
Moleculin Biotech (MBRX) posted quarterly Operating Leases of $222000.0 for Q4 2025, down 37.99% year-over-year from $358000.0 in Q4 2024, and down 13.95% quarter-over-quarter from $258000.0 in Q3 2025.
Moleculin Biotech (MBRX) Operating Leases (2019 - 2026) Analysis & Trends
Moleculin Biotech's Operating Leases history runs 7 years deep, the most recent figure standing at $222000.0 for Q4 2025.
- In Q4 2025, Operating Leases fell 37.99% year-over-year to $222000.0; the TTM figure through Dec 2025 stood at $222000.0 (down 37.99% YoY), while the FY2025 annual figure was $222000.0, down 37.99% from the prior year.
- Operating Leases for Q4 2025 stood at $222000.0, down from $258000.0 in the prior quarter.
- The five-year high for Operating Leases was $496000.0 in Q3 2023, with the low at $50000.0 in Q1 2022.
- The 5-year median for Operating Leases is $317000.0 (2023), against an average of $295200.0.
- The sharpest annual moves came in 2022 and 2023: Operating Leases sank 79.92% in 2022, then jumped 516.0% in 2023.
- Moleculin Biotech's Operating Leases stood at $63000.0 in 2021, then surged by 431.75% to $335000.0 in 2022, then jumped by 41.49% to $474000.0 in 2023, then dropped by 24.47% to $358000.0 in 2024, then slumped by 37.99% to $222000.0 in 2025.
- Business Quant data shows MBRX's Operating Leases at $222000.0 in Q4 2025, $258000.0 in Q3 2025, and $292000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - |
| 10 | Moleculin Biotech | 3.52 Mn | 3.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 147,000.00 |
| Dec 31, 2025 | 222,000.00 |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 390,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 474,000.00 |
| Sep 30, 2023 | 496,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 308,000.00 |
| Dec 31, 2022 | 335,000.00 |
| Sep 30, 2022 | 365,000.00 |
| Jun 30, 2022 | 388,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Sep 30, 2021 | 75,000.00 |
| Jun 30, 2021 | 94,000.00 |